# Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients

> **NCT05106491** · NA · NOT_YET_RECRUITING · sponsor: **Xenios AG** · enrollment: 21 (estimated)

## Conditions studied

- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation
- ECLS
- VA ECMO

## Interventions

- **DEVICE:** Synchronized Cardiac Support with the icor kit

## Key facts

- **NCT ID:** NCT05106491
- **Lead sponsor:** Xenios AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05106491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05106491, "Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05106491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*